Barclays PLC Gelesis Holdings, Inc. Transaction History

Barclays PLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 03, 2023	SELL	$0.01 - $0.2 $98 - $1,970	-9,853 Reduced 99.48%	52 $0
Q1 2023 May 04, 2023	BUY	$0.11 - $0.52 $561 - $2,656	5,108 Added 106.48%	9,905 $2,000
Q4 2022 Feb 13, 2023	BUY	$0.22 - $0.51 $909 - $2,107	4,133 Added 622.44%	4,797 $1,000
Q3 2022 Nov 03, 2022	BUY	$0.08 - $1.34 $12 - $207	155 Added 30.45%	664 $1,000
Q2 2022 Aug 12, 2022	BUY	N/A	509 New	509 $1,000

4.7K

Ticker GLS
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 72,946,704
Market Cap $1.46M
Description
Gelesis Holdings Inc., a commercial stage biotherapeutics company, developing a biomimicry to treat the genesis of obesity and GI-related chronic diseases. The company also provides PLENITY, an orally administered, non-stimulant, and non-systemic aid for weight management. In addition, it offers a product for obesity and overweight and a pipelin...

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

Stay updated on Barclays PLC with notifications on news.